MAGNSNOH NWACHUKU: Open Payments
NPI 1134972052 · NORTHBOROUGH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 27 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $590 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $275 |
| Otsuka America Pharmaceutical, Inc. | 9 | $181 |
| Lundbeck LLC | 5 | $116 |
| Indivior Inc. | 4 | $114 |
| Alkermes, Inc. | 1 | $93 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $32 |
Products named: REXULTI, CAPLYTA, SUBLOCADE, VIVITROL, SPRAVATO, COBENFY.
Industry payments across MA — which companies pay providers there.
